Jet Capital Investors L P Point Biopharma Global Inc. Transaction History
Jet Capital Investors L P
- $0
- Q3 2024
A detailed history of Jet Capital Investors L P transactions in Point Biopharma Global Inc. stock. As of the latest transaction made, Jet Capital Investors L P holds 164,600 shares of PNT stock, worth $0. This represents 4.86% of its overall portfolio holdings.
Number of Shares
164,600Holding current value
$0% of portfolio
4.86%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding PNT
# of Institutions
1Shares Held
20KCall Options Held
0Put Options Held
0About POINT Biopharma Global Inc.
- Ticker PNT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,025,000
- Description
- POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...